Virtual Library
Start Your Search
Anne Tsao
Moderator of
-
+
Immune Checkpoint Inhibitors + Chemo or Other Immune Combination Co-Stimulatory and Co-Inhibitor Molecules (ID 14)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 15
- Moderators:Dean Fennell, Anne Tsao
- Coordinates: 7/12/2019, 10:15 - 11:40, Westin New York at Times Square
-
+
Arginine Inhibitor + I/O (ID 109)
10:15 - 11:40 | Author(s): Melissa Johnson
- Abstract
Abstract not provided
-
+
B7H3 Inhibition + I/O (ID 112)
10:15 - 11:40 | Author(s): Corey Langer
- Abstract
Abstract not provided
-
+
DREAM Australia (ID 99)
10:15 - 11:40 | Author(s): Anna Nowak
- Abstract
Abstract not provided
-
+
INDUCE-1 GDK3359609 (ICOS) + I/O (ID 108)
10:15 - 11:40 | Author(s): Melissa Johnson
- Abstract
Abstract not provided
-
+
INITIATE (ID 104)
10:15 - 11:40 | Author(s): Paul Baas
- Abstract
Abstract not provided
-
+
Ipilimumab -Nivolumab vs Chemo Frontline (ID 103)
10:15 - 11:40 | Author(s): Arnaud Scherpereel
- Abstract
Abstract not provided
-
+
LAG525 + Spartalizumab (ID 107)
10:15 - 11:40 | Author(s): Tom Stinchcombe
- Abstract
Abstract not provided
-
+
MAPS 2 (ID 106)
10:15 - 11:40 | Author(s): Arnaud Scherpereel
- Abstract
Abstract not provided
-
+
NIBIT-MESO (ID 105)
10:15 - 11:40 | Author(s): Luana Calabr
- Abstract
Abstract not provided
-
+
Pembrolizumab + Anetumab (ID 111)
10:15 - 11:40 | Author(s): Aaron Mansfield
- Abstract
Abstract not provided
-
+
Pembrolizumab + Chemo (Canada) (ID 101)
10:15 - 11:40 | Author(s): Natasha Leighl
- Abstract
Abstract not provided
-
+
Pembrolizumab + CRS207 (ID 110)
10:15 - 11:40 | Author(s): Aaron Mansfield
- Abstract
Abstract not provided
-
+
PrE0505 Chemo + Durvalumab (ID 100)
10:15 - 11:40 | Author(s): Patrick Forde
- Abstract
Abstract not provided
-
+
PROMISE-mesoETOP (ID 102)
10:15 - 11:40 | Author(s): Sanjay Popat
- Abstract
Abstract not provided
-
+
Science of Combinations (ID 98)
10:15 - 11:40 | Author(s): Anna Nowak
- Abstract
Abstract not provided
Author of
-
+
DNA Repair Session (ID 6)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Isabelle Opitz, Michele Carbone
- Coordinates: 7/11/2019, 11:35 - 12:10, Westin New York at Times Square
-
+
Aurora Kinase Inhibitor (alisertib) (ID 40)
11:35 - 12:10 | Author(s): Anne Tsao
- Abstract
Abstract not provided
-
+
FGFR/PDGFR/Angiogenesis Session (ID 2)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 2
- Moderators:Giorgio Scagliotti, Mary Hesdorffer, NP
- Coordinates: 7/11/2019, 07:45 - 08:45, Westin New York at Times Square
-
+
Miscellaneous Session (ID 8)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Joachim Aerts, Arnaud Scherpereel
- Coordinates: 7/11/2019, 14:25 - 15:25, Westin New York at Times Square
-
+
Brentuximab (ID 50)
14:25 - 15:25 | Author(s): Anne Tsao
- Abstract
Abstract not provided
-
+
PANEL: NCI CTEP/FDA/Advocate Panel - Mesothelioma Research, Master Protocols UK, USA (ID 15)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Wolf Lindwasser
- Coordinates: 7/12/2019, 12:00 - 12:30, Westin New York at Times Square
-
+
PANEL: NCI CTEP/FDA/Advocate Panel - Mesothelioma Research, Master Protocols UK, USA (ID 118)
12:00 - 12:30 | Author(s): Anne Tsao
- Abstract
Abstract not provided
-
+
Surgically Resectable Session (ID 12)
- Event: MESO 2019
- Type: Session
- Track:
- Presentations: 1
- Moderators:Marc de Perrot, David Harpole
- Coordinates: 7/12/2019, 08:10 - 09:15, Westin New York at Times Square
-
+
S1619 (Chemo-Atezolizumab) (ID 90)
08:10 - 09:15 | Author(s): Anne Tsao
- Abstract
Abstract not provided